Cargando…
Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria
BACKGROUND: Parkinson’s disease (PD) is one of the neurodegeneration diseases characterized by the gradual loss of dopaminergic (DA) neurons in the substantia nigra region of the brain. Substantial evidence indicates that at the cellular level mitochondrial dysfunction is a key factor leading to pat...
Autores principales: | Cheng, Xiao-Yu, Biswas, Sangita, Li, Juan, Mao, Cheng-Jie, Chechneva, Olga, Chen, Jing, Li, Kai, Li, Jiao, Zhang, Jin-Ru, Liu, Chun-Feng, Deng, Wen-Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325238/ https://www.ncbi.nlm.nih.gov/pubmed/32345341 http://dx.doi.org/10.1186/s40035-020-00190-6 |
Ejemplares similares
-
Mitochondria fingerprint longevity in iPSCs
por: Masotti, Andrea, et al.
Publicado: (2015) -
Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells
por: Jin, Jinghua, et al.
Publicado: (2007) -
Lucky iPSCs
por: Zviran, Asaf, et al.
Publicado: (2014) -
iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017) -
Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
por: Arnst, Nikita, et al.
Publicado: (2021)